Problemi speciali
Quando il boccone non va giù: la disfagia in Pediatria attraverso i casi
When swallowing is a struggle: understanding dysphagia in Paediatrics through clinical cases
Giulia Capata1, Sara Lega2, Matteo Bramuzzo2, Grazia Di Leo2
1Scuola di Specializzazione in Pediatria, Università di Trieste
2SS di Gastroenterologia Pediatrica, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste
Novembre 2023 - pagg. 575 -579 | DOI: 10.53126/MEB42575
Abstract
Dysphagia is a disorder that affects one or more phases of the swallowing process. In paediatric age, it is often difficult to discriminate the underlying cause of this disorder. In this sense, a first distinction between oropharyngeal and oesophageal dysphagia is helpful. This article reviews the main causes of dysphagia through the description of clinical cases and provides indications for diagnostic and therapeutic management.
Riassunto
La disfagia è un disturbo che colpisce una o più fasi del processo di deglutizione. In età pediatrica è spesso difficile discriminare la causa alla base di questo disturbo. In questo senso è utile una prima distinzione tra disfagia orofaringea ed esofagea. Questo articolo passa in rassegna le principali cause di disfagia attraverso la descrizione di casi clinici e fornisce indicazioni per la gestione diagnostica e terapeutica.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Benfer KA, Weir KA, Bell KL, et al. Oropharyngeal dysphagia and gross motor skills in children with cerebral palsy. Pediatrics 2013;131(5):e1553-62. doi: 10.1542/ peds.2012-3093.
2. Durvasula VS, O’ Neill AC, Richter GT. Oropharyngeal dysphagia in children: mechanism, source and management. Otolaryngol Clin North Am 2014;47(5):691-720. doi: 10.1016/j.otc.2014.06.004.
3. Pascolo P. Tutti a tavola con… i bambini con disabilità. Medico e Bambino 2016;35(6): 395-7.
4. Arvedson JC. Assessment of pediatric dysphagia and feeding disorders: clinical and instrumental approaches. Dev Disabil Res Rev 2008;14(2):118-27. doi: 10.1002/ddrr.17.
5. Bua J, Marchetti F, Giuseppin I, et al. L’esofagite eosinofila. Che cos’è? Quando sospettarla? Come trattarla? La nostra esperienza. Medico e Bambino 2007;26(8):500-8.
6. Hirano I, Furuta GT. Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis. Gastroenterology 2020;158(4):840-51. doi: 10.1053/j.gastro.2019.09.052.
7. Murray FR, Kreienbuehl AS, Greuter T et al. Diagnostic delay in patients with eosinophilic esophagitis has not changed since the first description 30 years ago: diagnostic delay in eosinophilic esophagitis. Am J Gastroenterol 2022;117(11):1772-9. doi: 10. 14309/ajg.0000000000001950.
8. Kim HP, Vance RB, Shaheen NJ et al. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol 2012;10(9):988-96.e5. doi: 10.1016/j.cgh. 2012.04.019.
9. Hirano I, Collins MH, Katzka DA, et al. Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial. Clin Gastroenterol Hepatol 2022;20(3):525-34.e10. doi: 10. 1016/j.cgh.2021.04.022.
10. Dellon ES, Woosley JT, Arrington A et al. Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology 2019;157(1):65-73.e5. doi: 10.1053/j.gastro.2019.03.014.
11. Laserna-Mendieta EJ, Casabona S, Guagnozzi D et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther 2020;52 (5):798-807. doi: 10.1111/apt.15957.
12. Rank MA, Sharaf RN, Furuta GT et al. Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology 2020;158(6):1789-810.e15. doi: 10. 1053/j.gastro.2020.02.039.
13. Dellon ES, Rothenberg ME, Collins MH et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med 2022;387(25):2317-30. doi: 10.1056/NEJMoa 2205982.
14. Mainetti M, Troisi A, Turlà G, et al. Il dupilumab nell’esofagite eosinofila: una nuova frontiera? Medico e Bambino 2022;41(9):583-7. doi: 10.53126/MEB41583.
15. Van Hoeij FB, Ponds FA, Smout AJ, et al. Incidence and costs of achalasia in The Netherlands. Neurogastroenterol Motil 2018;30(2). doi: 10.1111/nmo.13195.
16. Rizzello E, Pellegrin MC, Dal Bo S, et al. Le molte facce dell’acalasia esofagea: promemoria per il pediatra. Medico e Bambino 2014;33(3):157-63.
17. Nassri A, Ramzan Z. Pharmacotherapy for the management of achalasia: current status, challenges and future directions. World J Gastrointest Pharmacol Ther 2015;6(4):145-55. doi: 10.4292/wjgpt.v6.i4.145.
18. Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med 2011;364(19):1807-16. doi: 10.1056/NEJMoa1010502.
19. Chen WF, Li QL, Zhou PH, et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc 2015;81(1):91-100. doi: 10.1016/j.gie. 2014.06.035.
20. Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders. Gastroenterology 2016:S0016-5085(16)00178-5. doi: 10.1053/j. gastro.2016.02.012.
Corrispondenza: giulia.capata@gmail.com